A phase I study of induction chemotherapy for older patients with newly diagnosed acute myeloid leukemia (AML) using mitoxantrone, etoposide, and the MDR modulator PSC 833: a Southwest Oncology Group study 9617
To access this article, please choose from the options below
PII: S0145-2126(00)00024-2
© 2000 Elsevier Science Ltd. All rights reserved.
